Johnson & Johnson (JNJ) Stock Price
Johnson & Johnson Price
Over the last 19 years Johnson & Johnson grew revenue by 3.0% annually, reaching 94.19 B USD. Earnings per share have grown at 5.8% per year over the last 19 years. For Johnson & Johnson, the net margin of 28.5% is up versus 26.5% a few years ago. At today's price the dividend yield works out to roughly 1.81%. The payout ratio is around 47% of earnings. The dividend has grown at 6.9% per year over the past 19 years. The consensus 12-month price target for Johnson & Johnson is 282.00 USD, about 0.5% below where the stock trades today. Of 30 analysts, 21 rate the stock a buy — an overall Buy consensus.
Johnson & Johnson stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Johnson & Johnson business model & stock analysis
Frequently asked questions about Johnson & Johnson
Johnson & Johnson operates under a diversified business model. The company is engaged in the development, manufacturing, and marketing of a wide range of healthcare products. Their business segments include pharmaceuticals, medical devices, and consumer health products. Johnson & Johnson is known for their innovative approach in creating advanced treatments and solutions for various health conditions and diseases. With a focus on research and development, they strive to provide high-quality products that improve the well-being of people around the world. Johnson & Johnson's commitment to delivering value to their customers and stakeholders drives their success in the global healthcare industry.
Johnson & Johnson is primarily active in the healthcare industry. With a diverse range of products, the company operates in multiple sectors such as pharmaceuticals, medical devices, and consumer health. Johnson & Johnson is renowned for its comprehensive portfolio that includes prescription drugs, over-the-counter medications, surgical equipment, contact lenses, and personal care products. Being a global leader, Johnson & Johnson's presence extends across various healthcare segments, enabling it to contribute significantly to advancing medical solutions and enhancing overall well-being.
Some of the main competitors of Johnson & Johnson in the market include Pfizer Inc., Merck & Co., Inc., and Roche Holding AG.
Johnson & Johnson is a multinational healthcare company that was founded in 1886. It has a rich history and has become a leader in the pharmaceutical, medical devices, and consumer healthcare sectors. With over 130 years of experience, Johnson & Johnson has continually focused on delivering innovative solutions to improve the health and well-being of people around the world. The company has grown through strategic acquisitions and partnerships, expanding its product portfolio and global presence. Johnson & Johnson's commitment to research and development, along with its dedication to ethical business practices, have made it a trusted name in the healthcare industry.
Some significant milestones achieved by Johnson & Johnson include the development of innovative medical treatments and breakthrough pharmaceutical products. Throughout its history, the company has also played a crucial role in the advancement of healthcare technology and the improvement of patient care. Johnson & Johnson has consistently demonstrated its commitment to quality and safety, earning a reputation as a trusted global healthcare leader. With a strong focus on research and development, the company has introduced numerous life-saving and life-enhancing solutions to address a wide range of medical needs. Through its dedication to innovation and excellence, Johnson & Johnson continues to shape the future of healthcare.
Johnson & Johnson is primarily present in several countries and regions worldwide. The company has a significant presence in the United States, where it is headquartered, and it operates in countries across North America, Europe, Asia Pacific, and Latin America. Some prominent regions where Johnson & Johnson operates include Canada, Germany, France, Japan, Australia, Brazil, and China. With its diverse portfolio of healthcare products and services, Johnson & Johnson continues to expand its presence globally, serving the healthcare needs of people in numerous countries and regions.
Johnson & Johnson is a renowned global healthcare company that upholds strong values and a clear corporate philosophy. With a commitment to improving the well-being of people worldwide, the company focuses on three fundamental principles: caring for the world, keeping customers at the center, and cherishing employees. Johnson & Johnson values integrity, innovation, diversity, and collaboration, consistently striving to deliver high-quality products and solutions. With a customer-centric approach, the company endeavors to create lasting relationships and enhance experiences. By fostering a supportive work environment and promoting professional growth, Johnson & Johnson ensures its employees play a vital role in achieving its mission.
Analysts currently set an average price target of 282.08 USD for the Johnson & Johnson stock (median: 282.00 USD), implying -1.5 % versus the latest price. The consensus is based on 30 analyst ratings.
30 analysts currently rate the Johnson & Johnson stock: 21 recommend buying, 9 holding and 0 selling. For 2026, analysts expect Johnson & Johnson to generate revenue of 101.22 B USD and earnings per share of 11.07 USD.
Converted at the current exchange rate, the Johnson & Johnson share trades at 256.86 EUR (283.52 USD).
The Johnson & Johnson share (JNJ) is listed on 12 stock exchanges, including: NYSE (JNJ), London (0R34.L), SIX (Zürich) (JNJUSD.SW), XETRA (JNJ.DE), Frankfurt (JNJ.F), München (JNJ.MU), Stuttgart (JNJ.SG), Düsseldorf (JNJ.DU).
Johnson & Johnson is one of the largest healthcare companies in the world. The company was founded in 1886 and is based in New Brunswick, New Jersey. With a wide portfolio of products and services, Johnson & Johnson is active in the consumer goods, medical technology, and pharmaceutical sectors. Consumer Goods: Johnson & Johnson is best known for its baby care products, such as diapers and wipes. The company also offers a wide range of other products, including personal care, wound healing, and pain relief products. Medical Technology: As a global leader in medical devices and instruments, Johnson & Johnson provides solutions for various areas of the medical field. In orthopedics, for example, the company offers implants for a variety of joints and bones. In medical imaging, Johnson & Johnson has a diverse range of devices that can be used for diagnosis and treatment. Pharmaceuticals: Johnson & Johnson is also active in the pharmaceutical business. The company is a global leader in the development and marketing of prescription drugs. In the field of oncology, for example, Johnson & Johnson offers various medications for the treatment of cancer. The company is also involved in neurology and immunology, offering a wide range of medications. Innovative Technologies: Johnson & Johnson heavily invests in innovative technologies to improve treatment options for patients. Examples of this include the "CaringCrowd" crowdfunding platform and the "Janssen Health EMEA Innovation Center," a platform for start-ups and companies focusing on groundbreaking innovations in healthcare. Research and Development: Research and development is a crucial aspect of Johnson & Johnson's business success. The company invests significant amounts each year in the research and development of new products and technologies. The goal is to develop products that meet the needs of patients and address various diseases and conditions. Johnson & Johnson also conducts extensive clinical studies to ensure the safety and efficacy of its products. Conclusion: Johnson & Johnson has a diverse range of products and services. The company is a leading provider in consumer goods, medical technology, and pharmaceuticals. It heavily invests in innovative technologies and research and development to offer treatment options to patients worldwide that meet the highest standards in terms of efficacy and safety. The output answer: Johnson & Johnson is a global healthcare company that offers a wide range of consumer goods, medical technology, and pharmaceutical products. It invests in innovative technologies and research and development to provide effective and safe treatment options for patients worldwide.
The expected revenue of Johnson & Johnson is 101.22 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Johnson & Johnson is 27.00 B USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Johnson & Johnson is currently 25.61. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Johnson & Johnson stock.
The price-to-sales ratio (P/S) of Johnson & Johnson is currently 6.83. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Johnson & Johnson stock.
The Eulerpool Quality Score for Johnson & Johnson is 7/10.
The ISIN of Johnson & Johnson is US4781601046. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Johnson & Johnson is 853260. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Johnson & Johnson is JNJ. The ticker symbol is used to trade Johnson & Johnson shares on the stock exchange.
Johnson & Johnson stock
Johnson & Johnson Peer Group
Johnson & Johnson Ticker
Johnson & Johnson FIGI
All fundamentals and in-depth analysis of Johnson & Johnson
Our stock analysis for Johnson & Johnson stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Johnson & Johnson. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.